FHTX
Foghorn Therapeutics Inc
4.20$
+2.2%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Cash Flow
Foghorn Therapeutics Inc (FHTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -86 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| -23 | -46 | -31 | -50 | 194 | -118 | -100 | -86 | |
| 0.4 | 0.7 | 1.3 | 3.2 | 7.9 | 3.5 | 3.1 | 3.3 | |
| 0.7 | 1.7 | 3.0 | 8.4 | 14 | 16 | 12 | 10 | |
| 0.9 | 2.9 | 7.5 | 9.9 | 14 | – | – | – | |
| 2.4 | 1.2 | 29 | 33 | 282 | -42 | -32 | -32 | |
| 1.5 | 1.0 | 16 | 3.3 | 1.2 | 1.2 | 0.9 | 0.1 | |
| -1.5 | -1.0 | -109 | 36 | -244 | 144 | -30 | 112 | |
| – | – | 123 | 44 | 1.8 | – | – | – | |
| 11 | 8.0 | 4.3 | -21 | 0.0 | – | – | – | |
| 52 | 24 | 217 | 22 | 1.8 | 1.8 | 105 | 1.0 | |
| 28 | -23 | 77 | 8.3 | -49 | 28 | -25 | 27 | |
| -24 | -47 | -47 | -54 | 192 | -119 | -101 | -86 |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.